Background: Obesity and overweight are widespread phenomena. Dyslipidaemia observed in obese people is an important risk factor for coronary heart disease. Levels of obesity have been shown to be associated with low-grade inflammation and C-reactive protein, an inflammatory marker has been associated with the presence and severity of atherosclerosis. Aims & Objective: To evaluate the Hs-CRP levels in overweight individuals with dyslipidaemia and without dyslipidaemia, and thus assess its role in detecting cardiovascular disease (CVD) in overweight individuals. Material and Methods: 120 overweight subjects were included in the study, they were divided into 2 groups-Group I which included subjects with dyslipidaemia and Group II included normolipemic subjects. BMI, Hs-CRP, Total Cholesterol, HDL
Background: The increase in the incidence of Diabetes in both the urban and rural sectors of population demands a proper screening strategy for early diagnosis, to delay the complications associated with this disorder. Aim: To evaluate HbA1c as a diagnostic tool for screening purposes at the community level. Materials and Methods: 50 Type 2 Diabetics were included as cases and 50 healthy individuals were taken as controls in this study. FBS and HbA1c were estimated in them, and the data was statistically analyzed using SPSS software version17. Results: A significantly (p<0.001) strong and positive correlation between FBS and HbA1c with a "r" value 0.908 was observed. HbA1c showed 100% sensitivity and specificity at a best cut off value of 6.7%. Conclusion: Hba1c can be used as an effective screening tool at the community level, provided that the test should be performed using a method that is standardized.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.